Eloxx Pharmaceuticals Probability of Future Pink Sheet Price Finishing Under 4.27
| ELOXDelisted Stock | USD 6.12 0.30 4.67% |
Eloxx |
Eloxx Pharmaceuticals Target Price Odds to finish below 4.27
The tendency of Eloxx Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 4.27 or more in 90 days |
| 6.12 | 90 days | 4.27 | about 11.58 |
Based on a normal probability distribution, the odds of Eloxx Pharmaceuticals to drop to $ 4.27 or more in 90 days from now is about 11.58 (This Eloxx Pharmaceuticals probability density function shows the probability of Eloxx Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Eloxx Pharmaceuticals price to stay between $ 4.27 and its current price of $6.12 at the end of the 90-day period is about 34.16 .
Given the investment horizon of 90 days Eloxx Pharmaceuticals has a beta of -2.75 suggesting as returns on its benchmark rise, returns on holding Eloxx Pharmaceuticals are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Eloxx Pharmaceuticals is expected to outperform its benchmark. In addition to that Eloxx Pharmaceuticals has an alpha of 2.233, implying that it can generate a 2.23 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Eloxx Pharmaceuticals Price Density |
| Price |
Predictive Modules for Eloxx Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eloxx Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Eloxx Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Eloxx Pharmaceuticals is not an exception. The market had few large corrections towards the Eloxx Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Eloxx Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Eloxx Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 2.23 | |
β | Beta against Dow Jones | -2.75 | |
σ | Overall volatility | 1.70 | |
Ir | Information ratio | 0.06 |
Eloxx Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Eloxx Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Eloxx Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Eloxx Pharmaceuticals is not yet fully synchronised with the market data | |
| Eloxx Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (36.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Eloxx Pharmaceuticals currently holds about 30.05 M in cash with (31.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.35. | |
| Latest headline from accesswire.com: CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM After Failure of Standard First Line Therapy |
Eloxx Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Eloxx Pink Sheet often depends not only on the future outlook of the current and potential Eloxx Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eloxx Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.2 M | |
| Cash And Short Term Investments | 19.2 M |
Eloxx Pharmaceuticals Technical Analysis
Eloxx Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Eloxx Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Eloxx Pharmaceuticals. In general, you should focus on analyzing Eloxx Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Eloxx Pharmaceuticals Predictive Forecast Models
Eloxx Pharmaceuticals' time-series forecasting models is one of many Eloxx Pharmaceuticals' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Eloxx Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Eloxx Pharmaceuticals
Checking the ongoing alerts about Eloxx Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Eloxx Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Eloxx Pharmaceuticals is not yet fully synchronised with the market data | |
| Eloxx Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (36.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Eloxx Pharmaceuticals currently holds about 30.05 M in cash with (31.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.35. | |
| Latest headline from accesswire.com: CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM After Failure of Standard First Line Therapy |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Eloxx Pink Sheet
If you are still planning to invest in Eloxx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eloxx Pharmaceuticals' history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |